Literature DB >> 23070707

Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?

Akesbi Jad1, Terrada Céline, Bodaghi Bahram, LeHoang Phuc, Cassoux Nathalie.   

Abstract

The purpose of this article is to report the development of Fuchs' heterochromic cyclitis (FHC) secondary to toxoplasmosis chorioretinitis. The design is based on observational case series report. We report in this article six cases of typical FHC developing secondary to ocular toxoplasmosis. Intraocular immunoglobulin G production against Toxoplasma gondii was determined in the aqueous humor of five patients by calculation of the Goldmann-Witmer coefficient (GWC). The clinical examination revealed typical FHC with no active chorioretinal scar. We report on five women and one man (aged 33-64 years old; median 44.6 years) who developed FHC over a period of time ranging from 2-13 years. A positive GWC (>3) was found in four patients; of the two remaining patients one was negative and the other did not have anterior chamber paracentesis. Four patients were treated for an active ocular toxoplasmic lesion before the development of FHC with pyrimethamine, sulfadiazine and corticosteroids. Two patients had negative anti-toxoplasmic therapy for FHC (one with trimethoprim-sulfamethoxazole for 3 weeks and the other with pyrimethamine, sulfadiazine and corticosteroids for 8 weeks). One never had any treatment. All the patients had mild anterior chamber reaction with no synechia, diffuse and characteristic white stellate keratic precipitates and vitritis; five patients had posterior subcapsular cataract and heterochromia and three had elevated intraocular pressure. The findings help us to conclude that FHC can develop over a period of time after ocular toxoplasmosis. This could be a main association to search for when a Fuchs' uveitis is found with a chorioretinal scar. Ocular inflammation does not mean reactivation of ocular toxoplasmosis. FHC could be a secondary immune reaction with a past antigenic stimulation to a previous infection, i.e., toxoplasmosis, etc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23070707     DOI: 10.1007/s10792-012-9649-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  27 in total

Review 1.  T-cell subsets (Th1 versus Th2).

Authors:  S Romagnani
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

2.  High incidence of corneal epithelium antibodies in Fuch's heterochromic cyclitis.

Authors:  E la Hey; G S Baarsma; A Rothova; L Broersma; R van der Gaag; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1988-12       Impact factor: 4.638

Review 3.  Fuchs' heterochromic cyclitis: review of the literature on the pathogenetic mechanisms.

Authors:  E La Hey; P T de Jong; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

4.  Fuchs' heterochromic iridocyclitis following bilateral ocular toxoplasmosis.

Authors:  Sudha K Ganesh; Sumita Sharma; Kannan M Narayana; Jyotirmay Biswas
Journal:  Ocul Immunol Inflamm       Date:  2004-03       Impact factor: 3.070

5.  Does autoimmunity to S-antigen play a role in Fuchs' heterochromic cyclitis?

Authors:  E La Hey; L Broersma; R van der Gaag; G S Baarsma; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

6.  A feline model of ocular toxoplasmosis.

Authors:  M G Davidson; M R Lappin; R V English; M B Tompkins
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-12       Impact factor: 4.799

7.  Rubella virus-associated uveitis: clinical manifestations and visual prognosis.

Authors:  Lenneke de Visser; Arthur Braakenburg; Aniki Rothova; Joke H de Boer
Journal:  Am J Ophthalmol       Date:  2008-06-10       Impact factor: 5.258

8.  Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth.

Authors:  R E Gilbert; M R Stanford; H Jackson; R E Holliman; M D Sanders
Journal:  BMJ       Date:  1995-04-22

9.  Fuchs' heterochromic cyclitis and ocular toxoplasmosis.

Authors:  M Toledo de Abreu; R Belfort; P S Hirata
Journal:  Am J Ophthalmol       Date:  1982-06       Impact factor: 5.258

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  4 in total

1.  Treatment of Complications Due to Fuchs Heterochromic Iridocyclitis (FHI) - a Case Report.

Authors:  Melita Adilovic; Majda Kalabic; Arnes Cabric; Darija Becirovic
Journal:  Acta Inform Med       Date:  2022-06

2.  [Differential diagnosis of anterior uveitis].

Authors:  S Thurau; U Pleyer
Journal:  Ophthalmologe       Date:  2016-10       Impact factor: 1.059

3.  Classification Criteria for Fuchs Uveitis Syndrome.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

4.  Cytokine Changes in the Aqueous Humor in Rubella-Related Fuchs Heterochromic Iridocyclitis.

Authors:  Yi Mao; Sijie Lin; Chengfang Zhu; Xiaodong Liu; Huping Wu; Shangkun Ou
Journal:  Dis Markers       Date:  2022-02-07       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.